Biomerica Approved to Distribute Two Diagnostic Tests in China

Biomerica, a Los Angeles maker of diagnostic tests, said the CFDA has approved China use for two sets of tests: Parathyroid Hormone (PTH) and Calcitonin. Biomerica also said the products will be distributed in China through a distribution channel that is unrelated to Biomerica's current China distributor. Although Biomerica did not name the new distributor, it did describe the company as one of China’s top three suppliers of Vitamin D tests, a related product. More details.... Stock Symbol: (OTCBB: BMRA) Share this with colleagues: // //